Category: Finance

Google Stock GOOGL NASDAQ GOOGL Financial News
Analysis, Finance, Mobile

Android One initiative launched by Google Inc (NASDAQ:GOOG)

Google Inc (NASDAQ:GOOG) launched the Android 1 initiative on Wednesday at Google I/O. This initiative is designed for manufacturers to develop a high quality low cost device. This initiative is set to enter the Indian market this fall, with a possible Global roll out to follow soon. Indian mobile market is considered as one of the fastest growing mobile markets in the world. This Google … Continue reading Android One initiative launched by Google Inc (NASDAQ:GOOG)

Richard Atkins
Finance

Top Gainers: Hovnanian Enterprises (NYSE:HOV), Scorpio Tankers (NYSE:STNG), CBS Corporation (NYSE:CBS), Apollo Education Group Inc (NASDAQ:APOL), Monsanto Company (NYSE:MON)

Hovnanian Enterprises, Inc. (NYSE:HOV) New Jersey’s largest homebuilder, is optimistic that demand will continue to rise though sales have been uneven in recent months. “While the housing market has improved dramatically overall compared to where it was a couple of years ago, the recent recovery has been a little more choppy,” Chief Executive Officer Ara Hovnanian said during an earnings conference call on June 4. … Continue reading Top Gainers: Hovnanian Enterprises (NYSE:HOV), Scorpio Tankers (NYSE:STNG), CBS Corporation (NYSE:CBS), Apollo Education Group Inc (NASDAQ:APOL), Monsanto Company (NYSE:MON)

Kristen Barton
Finance

Biotech New Highs: Celgene Corporation (NASDAQ:CELG), Omeros Corporation (NASDAQ:OMER), Repligen Corporation (NASDAQ:RGEN), Pain Therapeutics, Inc. (NASDAQ:PTIE)

Celgene Corporation (NASDAQ:CELG)’s stock had its “outperform” rating restated by Credit Suisse in a research note issued on Thursday. They currently have a $225.00 price target on the stock, up from their previous price target of $210.00. Credit Suisse’s target price would suggest a potential upside of 31.23% from the company’s current price. Celgene Corporation (NASDAQ:CELG) stock performance was 0.88% in last session and finished … Continue reading Biotech New Highs: Celgene Corporation (NASDAQ:CELG), Omeros Corporation (NASDAQ:OMER), Repligen Corporation (NASDAQ:RGEN), Pain Therapeutics, Inc. (NASDAQ:PTIE)

Richard Atkins
Finance

Biotech Volatile Stocks: Ultragenyx Pharmaceutical (NASDAQ:RARE), Sorrento Therapeutics (NASDAQ:SRNE), Five Prime Therapeutics (NASDAQ:FPRX), Aratana Therapeutics (NASDAQ:PETX), Pain Therapeutics (NASDAQ:PTIE)

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the presentation of results from a multiple-dose study, conducted by Kyowa Hakko Kirin Pharma, Inc. (KKP), of the investigational anti-FGF23 monoclonal antibody KRN23 (UX023) in adult patients with X-linked hypophosphatemia (XLH). XLH is an inherited metabolic bone disease characterized by short stature, skeletal deformities, … Continue reading Biotech Volatile Stocks: Ultragenyx Pharmaceutical (NASDAQ:RARE), Sorrento Therapeutics (NASDAQ:SRNE), Five Prime Therapeutics (NASDAQ:FPRX), Aratana Therapeutics (NASDAQ:PETX), Pain Therapeutics (NASDAQ:PTIE)

Jayne Crisman
Finance

Biotech Insider Buying: Merrimack Pharmaceuticals (NASDAQ:MACK), Omeros (NASDAQ:OMER), Insys Therapeutics (NASDAQ:INSY), Agios Pharmaceuticals (NASDAQ:AGIO), BioTime (NYSEMKT:BTX)

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Director Gary L. Crocker bought 36,000 shares of the stock in a transaction dated Monday, June 23rd. The shares were purchased at an average price of $6.84 per share, with a total value of $246,240.00. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stock performance was 3.91% in last session and finished the day at $7.44. Traded volume was 1.38million shares in the last session … Continue reading Biotech Insider Buying: Merrimack Pharmaceuticals (NASDAQ:MACK), Omeros (NASDAQ:OMER), Insys Therapeutics (NASDAQ:INSY), Agios Pharmaceuticals (NASDAQ:AGIO), BioTime (NYSEMKT:BTX)

Ryan Holtz
Finance

Basic Material Losers: Oxford Resource Partners (NYSE:OXF), Mines Management (NYSEMKT:MGN), USEC (NYSE:USU), Alexco Resource (NYSEMKT:AXU), New Concept Energy (NYSEMKT:GBR)

Oxford Resource Partners, LP (NYSE:OXF) expected to produce between 5.7 mln tons and 6.0 mln tons for FY 2014.Expects FY 2014 adjusted EBITDA to be in range of $40 mln to $45 mln.FY 2014 EBITDA of $46 mln. Oxford Resource Partners, LP (NYSE:OXF) stock performance was -7.00% in last session and finished the day at $0.930. Traded volume was 45,492.00million shares in the last session … Continue reading Basic Material Losers: Oxford Resource Partners (NYSE:OXF), Mines Management (NYSEMKT:MGN), USEC (NYSE:USU), Alexco Resource (NYSEMKT:AXU), New Concept Energy (NYSEMKT:GBR)

Kristen Barton